Dr Reddys Laboratories (RDY) Divestments (2017 - 2025)

Dr Reddys Laboratories' Divestments history runs 9 years deep, the most recent figure standing at -$224.3 million for Q2 2025.

• In Q2 2025, Divestments rose 7.61% year-over-year to -$224.3 million; the TTM figure through Jun 2025 stood at -$307.6 million (down 122.88% YoY), while the FY2024 annual figure was $5.4 million, changed N/A from the prior year.
• Divestments was -$224.3 million for Q2 2025 at Dr Reddys Laboratories, up from -$242.7 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $313.6 million in Q1 2024 to a low of -$321.7 million in Q4 2022.
• Historically, Divestments has averaged -$69.6 million across 5 years, with a median of -$69.9 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Divestments surged 420.19% in 2021, then slumped 772.92% in 2022.
• A 5-year view of Divestments shows it stood at -$36.8 million in 2021, then plunged by 772.92% to -$321.7 million in 2022, then surged by 52.03% to -$154.3 million in 2023, then sank by 57.32% to -$242.7 million in 2024, then rose by 7.61% to -$224.3 million in 2025.
• The last three Divestments figures came in at -$224.3 million (Q2 2025), -$242.7 million (Q2 2024), and $313.6 million (Q1 2024), per Business Quant data.